The Impacts of Intermittent Chest Tube Clamping on Chest Tube Drainage Duration and Postoperative Hospital Stay After Lung Cancer Surgery
1 other identifier
interventional
180
1 country
1
Brief Summary
All patients undergo lateral thoracotomy or video-assisted thoracoscopic surgery (VATS) and are operated on by the same thoracic surgical team. All patients are managed with gravity drainage (water seal only, without suction) on the day of operation. Eligible patients are randomized to control group or clamping group at a 1:1 ratio before 3pm on the postoperative day. Patients in control group and those in clamping group are managed with different protocols after 3pm on the postoperative day.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 26, 2017
CompletedFirst Submitted
Initial submission to the registry
September 30, 2017
CompletedFirst Posted
Study publicly available on registry
December 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 28, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 28, 2021
CompletedJuly 20, 2021
July 1, 2021
3.8 years
September 30, 2017
July 18, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
chest tube drainage duration
time from operation day to the day of chest tube removal
From date of operation until the date of chest tube removal, assessed up to 10 days
Secondary Outcomes (1)
postoperative hospital stay
From date of operation until the date of hospital discharge, assessed up to 2 weeks
Other Outcomes (3)
decrease of hemoglobin level
postoperative day 1, before hosptital discharge and 1 month after the operation
decrease of serum albumin level
postoperative day 1, before hosptital discharge and 1 month after the operation
pleural effusion thickness
observed through CT scan 1 month after the operation
Study Arms (2)
clamping group
EXPERIMENTALClamping group are managed with clamping protocol after 3pm on the postoperative day as follow: the chest tube will be clamped, and the nurses will check the patient every 6 h. If the patient has no problems with compliance, the clamp will be removed for half an hour in the morning to record the drainage volume every 24 h.
control group
NO INTERVENTIONPatients in control group are managed with gravity drainage (water seal only, without suction) all the time after operation.
Interventions
Clamping group are managed with clamping protocol after 3pm on the postoperative day as follow: the chest tube will be clamped, and the nurses will check the patient every 6 h. If the patient has no problems with compliance, the clamp will be removed for half an hour in the morning to record the drainage volume every 24 h.
Eligibility Criteria
You may qualify if:
- Pathological diagnosis of lung cancer Treated with lobectomy and systematic mediastinal lymph node dissection/ systematic sampling Managed with gravity drainage (water seal only, without suction) Re-expansion of the lung confirmed on the morning of the first postoperative day
You may not qualify if:
- Thoracic cavity infection Prolonged air leakage Reoperation due to chylothorax Atelectasis Liver cirrhosis Renal insufficiency Wound infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wu Nanlead
Study Sites (1)
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
Related Publications (1)
Wang Y, Pei Y, Lv C, Wang Y, Wang J, Zhao D, Li X, Yang Y, Kim AW, Toker A, Yan S, Wu N. Intermittent chest tube clamping decreases chest tube duration time and drainage volume after lung cancer surgery in patients without air leak: an open-label, randomized controlled trial. Transl Lung Cancer Res. 2022 Mar;11(3):357-365. doi: 10.21037/tlcr-22-150.
PMID: 35399576DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant of hospital director
Study Record Dates
First Submitted
September 30, 2017
First Posted
December 20, 2017
Study Start
July 26, 2017
Primary Completion
April 28, 2021
Study Completion
May 28, 2021
Last Updated
July 20, 2021
Record last verified: 2021-07